valıdıty and relıabılıty of the turkısh versıon of the functıonal mobılıty Scale ın ındıvıduals wıth Cerebral Palsy
FMS
1 other identifier
observational
83
1 country
1
Brief Summary
Cerebral palsy (CP) describes a group of persistent disorders in movement and postural development that cause activity limitation, attributed to non-progressive disturbances occurring in the developing fetal or infant brain. Motor disorders of cerebral palsy are often accompanied by sensory, perception, cognition, communication and behavioral disorders due to epilepsy and secondary musculoskeletal problems.(Rosenbaum et al. 2007) Within the ICF, body functions are the physiological functions of body systems and anatomical parts of the body, such as body structures, organs, limbs, and components. Disorders are problems that appear as a significant deviation or loss in body functions or structure. The primary injury in CP is a brain lesion resulting from an upper motor neuron lesion that is thought to have a number of positive and negative features. Positive traits include spasticity, hyperreflexia, and co-contraction, while negative traits include weakness, loss of selective motor control, and balance and coordination deficits. The aim of the study is to examine the validity and reliability of the Turkish version of the Functional Mobility Scale (FMS) in individuals with cerebral palsy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2021
CompletedFirst Submitted
Initial submission to the registry
October 1, 2021
CompletedFirst Posted
Study publicly available on registry
December 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 20, 2022
CompletedSeptember 27, 2024
September 1, 2024
8 months
October 1, 2021
September 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
functional mobility scale
6 points, Independent on all surfaces. It does not use any walking aids or require the assistance of another person when walking on all surfaces, including uneven floors. (sidewalks etc. and in a crowded environment.) 5 points, Independent on flat surfaces. Does not use walking aids or need someone else's help. It needs handrails for stairs. 4 points, uses a cane (one or two). Walks without the help of another person. 3 points uses crutches without someone else's help. 2 points use walker without anyone else's help. 1 point, Uses a wheelchair. Can stop for transfers, take a few steps assisted by another person or using a walker. C = Crawling: Child crawls (5m) to be able to move around the house. N = not valid : For example the child does not complete the distance ( 500 m ) .
2 week
Study Arms (1)
grup 1
GMFCS PEDİ ABİLOCO-KİDS FMS
Interventions
Eligibility Criteria
Patients aged 4-18 years diagnosed with cerebral palsy
You may qualify if:
- to 18 years of age
- Being diagnosed with cerebral palsy
- The GMFCS level was determined to be between I-IV.
You may not qualify if:
- The parent who will answer the form does not know Turkish.
- Performing orthopedic surgery and botulinum toxin injection in the previous six months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nursena Güçlülead
- Kırıkkale Universitycollaborator
Study Sites (1)
Yeni Kurtuluş Özel Eğitim Ve Rehabilitasyon Merkezi
Ankara, Altındağ, 06230, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
saniye arslan
kırıkkale üniversitesi
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 14 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- physiotherapist
Study Record Dates
First Submitted
October 1, 2021
First Posted
December 6, 2021
Study Start
September 15, 2021
Primary Completion
April 30, 2022
Study Completion
May 20, 2022
Last Updated
September 27, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share